Dave HodesNovember 18, 2022
Investors say the company made false statements in a recent SEC filing.
Tag: MindMed
Dave HodesNovember 18, 2022Dave HodesOctober 21, 2022
MindMed saw several management changes over the last nine months.
Dave HodesSeptember 30, 2022
To broaden the appeal of therapist-assisted psychedelics, a number of companies are engineering out the hallucinogenic aspect.
Debra BorchardtSeptember 28, 2022Co-founder was against the offering and suggested it would hurt the share price.
Dave HodesSeptember 7, 2022
Any analyst knows that market-reactive swings aren’t really a true indicator of what is going on inside a company.
Dave HodesAugust 23, 2022
To talk about company resilience in the psychedelics industry is a bit premature. After all, most of the more prominent companies didn’t open their doors until 2016 or later. But it’s the perfect time to build a foundation for resilience while they look to a future of opportunity. Established life science businesses can help show […]
StaffAugust 12, 2022
After the market closed on Thursday, Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) reported its financial results for the quarter ending June 30, 2022. At this time the company has no revenue and reported a net loss of $17.1 million versus $44.5 million for the same period in 2021. “In the second quarter, we took important steps […]
Dave HodesJuly 11, 2022
The psychedelics renaissance is in an expanded growth mode, not just in the U.S. and Canada, but in other countries as well. But everywhere in the world, it’s a bit of a Dr. Jekyll/Mr. Hyde scenario: startup businesses ostensibly building a serious moneymaking enterprise in a nascent industry, while conducting experiments in labs with novel […]
Dave HodesJune 8, 2022
You’ve read the predictions, you’ve heard the buzz—psychedelics are about to change the world of mental health treatment. They promise no more mental health pharmaceuticals that numb out the brain, or that help mask the side effects. No more taking chemicals for the rest of your life that are not body-friendly, with the caveat that […]
Dave HodesApril 19, 2022
The year 2021 has not been kind to the psychedelics industry. The stock performances of the 60 publicly traded psychedelics companies on the Psychedelic Stock Index have been trending steadily downward since February 22, 2021, to their lowest point since the index began on June 1, 2020. The pandemic has definitely affected psychedelic business development. […]
Get the latest cannabis news delivered right to your inbox
Unpack the industry with the daily cannabis newsletter for business leaders.